Related Experiment Video
Updated: Jan 19, 2026
08:35
Lipid Bilayer Vesicle Generation Using Microfluidic Jetting
Published on: February 21, 2014
15.4K
Generating Giant Membrane Vesicles from Live Cells with Preserved Cellular Properties
Qiaoling Liu1, Cheng Bi1, Jiangling Li1
1Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, China.
Research (Washington, D.C.)
|September 25, 2019
Summary
Researchers developed a new method to create biocompatible giant membrane vesicles (GMVs) from mammalian cells. These cell-derived GMVs are ideal for drug delivery applications, offering a promising platform for potential clinical use.
Area of Science:
- Biotechnology
- Biomaterials Science
- Cell Biology
Background:
- Biomimetic giant membrane vesicles (GMVs) are cell-sized models for studying membrane properties.
- Existing methods for GMV production involve chemical vesiculants and osmotic buffers, limiting their application.
- Cell-derived GMVs offer superior biomimicry but require improved production strategies.
Purpose of the Study:
- To develop a facile and biofriendly strategy for producing high-yield giant membrane vesicles (GMVs) from mammalian cells.
- To demonstrate the preservation of membrane properties and adaptability of these GMVs for various biological applications.
- To explore the potential of these GMVs as a drug delivery platform for targeted cancer therapy.
Main Methods:
- Developed a novel, facile strategy for deriving giant membrane vesicles (GMVs) from mammalian cells.
- Utilized a biofriendly medium, avoiding chemical vesiculants and osmotic buffers.
- Characterized GMVs for preserved membrane properties, surface modification adaptability, and encapsulation efficiency.
Main Results:
- Successfully derived giant membrane vesicles (GMVs) from mammalian cells with high yields in a biofriendly medium.
- Demonstrated that these GMVs retain native membrane properties and allow for surface modification and molecule encapsulation.
- Showcased the potential of drug-loaded GMVs for targeted delivery to tumor cells, indicating a significant advancement in biomedical applications.
Conclusions:
- The developed strategy provides a biocompatible platform for producing giant membrane vesicles (GMVs) with biomimicking properties.
- These GMVs exhibit adaptability for surface modification and encapsulation, making them ideal for diverse biological applications.
- The study highlights the potential of these GMVs as an advanced drug delivery system with promising clinical applications.
